Amalgam recently won an award for Best SaaS-Enabled Digital Health Platform.
Telehealth
Telehealth News Roundup – January 2022
As Nemphos Braue continues to support clients in the telehealth industry, the topic continues to make headlines — not only in the throes of a pandemic, but also as technology meets patients where they are.
Telehealth and Maryland Legislation: 2021 and Beyond
As the world pivoted to telehealth options during the pandemic, legislation from this past session and in the future will provide guidance for providers and patients. Telehealth is here to stay.
Nemphos Braue Represents Amalgam Rx in Acquisition of Avhana Health
Amalgam Rx Inc., a growing digital health company represented by Baltimore-based boutique law firm Nemphos Braue LLC, has completed its acquisition of Avhana Health Inc., creator of a SaaS-based tool integrated with the leading electronic health records (EHR) companies.
Latest Insights
View All
CTA Update: New Deadline Now in Effect
BOI reporting requirements under the CTA are back in effect. The new deadline for most reporting companies is now March 21, 2025.
Trade Secrets and MedTech: IP in the News
The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
MedTech M&A is Poised for Growth
In MedTech Dive, Nemphos Braue highlights 5 reasons why healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase.
